The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Clinical and Biologic Activity of an Estrogenic Herbal Combination (PC-SPES) in Prostate Cancer
Open accessAbstract
BACKGROUND: Herbal mixtures are popular alternatives to demonstrated therapies. PC-SPES, a commercially available combination of eight herbs, is used as a nonestrogenic treatment for cancer of the prostate. Since other herbal medicines have estrogenic effects in vitro, we tested the estrogenic activity of PC-SPES in yeast and mice and in men with prostate cancer. METHODS: We measured the estrogenic activity of PC-SPES with transcriptional-activation assays in yeast and a biologic assay in mice. We assessed the clinical activity of PC-SPES in eight patients with hormone-sensitive prostate cancer by measuring serum prostate-specific antigen and testosterone concentrations during and after treatment. RESULTS: In complementary yeast assays, a 1:200 dilution of an ethanol extract of PC-SPES had estrogenic activity similar to that of 1 nM estradiol, and in ovariectomized CD-1 mice, the herbal mixture increased uterine weights substantially. In six of six men with prostate cancer, PC-SPES decreased serum testosterone concentrations (P<0.05), and in eight of eight patients it decreased serum concentrations of prostate-specific antigen. All eight patients had breast tenderness and loss of libido, and one had venous thrombosis. High-performance liquid chromatography, gas chromatography, and mass spectrometry showed that PC-SPES contains estrogenic organic compounds that are distinct from diethylstilbestrol, estrone, and estradiol. CONCLUSIONS: PC-SPES has potent estrogenic activity. The use of this unregulated mixture of herbs may confound the results of standard or experimental therapies and may produce clinically significant adverse effects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Unconventional medicine in the United States-Prevalence, costs, and patterns of use
Eisenberg, D. M., Kessler, R. C., Foster, C., Norlock, F. E., Calkins, D. R., & Delbanco, T. L. (1993) · New England Journal of Medicine · doi:10.1056/nejm199301283280406 · Cited by 4,177
McDonnell, T. J., Troncoso, P., Brisbay, S. M., Logothetis, C. J., Chung, L. W. K., Hsieh, J., Tu, S., & Campbell, M. L. (1992) · PubMed · Cited by 1,049
Leuprolide versus Diethylstilbestrol for Metastatic Prostate Cancer
The Leuprolide Study Group (1984) · New England Journal of Medicine · doi:10.1056/nejm198411153112004 · Cited by 622
Carraro, J.-C., Raynaud, J.-P., Koch, G., Chisholm, G. D., Di Silverio, F., Teillac, P., Da Silva, F. C., Cauquil, J., Chopin, D. K., Hamdy, F. C., et al. (1996) · The Prostate · doi:10.1002/(sici)1097-0045(199610)29:4<231::aid-pros4>3.0.co;2-e · Cited by 340
See, D. M., Broumand, N., Sahl, L., & Tilles, J. G. (1997) · Immunopharmacology · doi:10.1016/s0162-3109(96)00125-7 · Cited by 258
Induction of Apoptosis by Diethylstilbestrol in Hormone-Insensitive Prostate Cancer Cells
Robertson, C. N., Roberson, K. M., Padilla, G. M., O'Brien, E. T., Cook, J. M., Kim, C.-S., & Fine, R. L. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.13.908 · Cited by 190
Controlled Clinical Trials of Hypericum Extracts in Depressed Patients - an Overview
Volz, H.-P. (1997) · Pharmacopsychiatry · doi:10.1055/s-2007-979522 · Cited by 173
Cancer patients use of nonproven therapy: a 5-year follow-up study.
Risberg, T., Lund, E., Wist, E., Kaasa, S., & Wilsgaard, T. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.1.6 · Cited by 130
Functional analysis of the human estrogen receptor using a phenotypic transactivation assay in yeast
Pierrat, B., Heery, D. M., Lemoine, Y., & Losson, R. (1992) · Gene · doi:10.1016/0378-1119(92)90277-v · Cited by 61
Testosterone metabolism in primary cultures of human prostate epithelial cells and fibroblasts
́los, S. D., Carsol, J.-L., Ghazarossian, E., Raynaud, J., & Martin, P. (1995) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(95)00184-0 · Cited by 55
Cited by
Messing, E. M., Manola, J., Sarosdy, M., Wilding, G., Crawford, E. D., & Trump, D. (1999) · New England Journal of Medicine · doi:10.1056/nejm199912093412401 · Cited by 1,191
Review of Pharmacological Effects of Glycyrrhiza sp. and its Bioactive Compounds
Asl, M. N., & Hosseinzadeh, H. (2008) · Phytotherapy Research · doi:10.1002/ptr.2362 · Cited by 1,136
Richardson, M. A., Sanders, T., Palmer, J. L., Greisinger, A., & Singletary, S. E. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.13.2505 · Cited by 1,022
Alternative Medicine — The Risks of Untested and Unregulated Remedies
Angell, M., & Kassirer, J. P. (1998) · New England Journal of Medicine · doi:10.1056/nejm199809173391210 · Cited by 688
Herbal Remedies in the United States: Potential Adverse Interactions With Anticancer Agents
Sparreboom, A., Cox, M. C., Acharya, M. R., & Figg, W. D. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.08.182 · Cited by 473
Metadata
- Authors
- DiPaola, R. S., Zhang, H., Lambert, G. H., Meeker, R., Licitra, E., Rafi, M. M., Zhu, B. T., Spaulding, H., Goodin, S., Toledano, M. B., Hait, W. N., & Gallo, M. A.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 1998-09-17
- Volume
- 339
- Issue
- 12
- Pages
- 785-791
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2028168267
- Cited by
- 290
- References
- 16
- FWCI
- 28.11
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Clinical and Biologic Activity of an Estrogenic Herbal Combination (PC-SPES) in Prostate Cancer. https://app.cochat.ai/papers/10.1056/nejm199809173391201
- The paper
- DiPaola, R. S., Zhang, H., Lambert, G. H., Meeker, R., Licitra, E., Rafi, M. M., Zhu, B. T., Spaulding, H., Goodin, S., Toledano, M. B., Hait, W. N., & Gallo, M. A. (1998). Clinical and Biologic Activity of an Estrogenic Herbal Combination (PC-SPES) in Prostate Cancer. New England Journal of Medicine. https://doi.org/10.1056/nejm199809173391201
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.